Status:

COMPLETED

Comparison of Cardiac Computed Tomography and Vasodilator Stress Magnetic Resonance Imaging Perfusion in Patients With Prior Equivocal Stress Test for Detection of Coronary Artery Disease

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18-100 years

Brief Summary

Background: * Noninvasive cardiac stress testing is imperfect. Inconclusive test results generate further expensive testing. * In patients with known or suspected coronary artery disease, both comput...

Detailed Description

Noninvasive cardiac stress testing is imperfect. Inconclusive test results generate further expensive testing. We will do both cardiac computed tomography (CT) and stress cardiac magnetic resonance im...

Eligibility Criteria

Inclusion

  • GENERAL INCLUSION CRITERIA:
  • 18 years of age and older
  • Prior equivocal stress study within the preceding 90 days
  • Able to provide informed consent
  • MEDICAL EXCLUSION CRITERIA:
  • Decompensated heart failure (unable to lie flat during MRI or CT)
  • Severe kidney disease (MDRD estimated Glomerular Filtration Rate less than 30mL/min/1.73m(2).
  • Prior cardiac revascularization with coronary stent or bypass surgery
  • Resting tachycardia (HR greater than l00 bpm)
  • Pregnant women (when uncertain, subjects will undergo urine or blood testing)
  • Lactating women (unless they are willing to discard breast milk for 24 hours after receiving gadolinium)
  • Second (Type II) and third degree atrioventricular heart block
  • Asthma or chronic pulmonary disease (emphysema) actively treated with bronchodilators or leukotriene antagonists
  • MRI EXCLUSION CRITERIA:
  • Cardiac pacemaker or implantable defibrillator
  • Cerebral aneurysm clip
  • Neural stimulator (e.g. TENS-Unit)
  • Any type of ear implant
  • Ocular foreign body (e.g. metal shavings)
  • Any implanted device (e.g. insulin pump, drug infusion device)
  • Metal shrapnel or bullet

Exclusion

    Key Trial Info

    Start Date :

    July 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    November 19 2020

    Estimated Enrollment :

    109 Patients enrolled

    Trial Details

    Trial ID

    NCT00929227

    Start Date

    July 1 2009

    End Date

    November 19 2020

    Last Update

    December 3 2021

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Suburban Hospital

    Bethesda, Maryland, United States, 20814

    2

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892